Skip to main content
Kidney Failure, ChronicHealthy volunteersKidney and urinaryDrugPhase 1

What this study is

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.

What's being tested

  • Golcadomide

    Intervention · DRUG

    Specified dose on specified days

Study details

Official title
A Phase 1, Multi-center, Single-dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of Golcadomide (BMS-986369) in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
Sponsor
Bristol-Myers Squibb
Conditions
Kidney Failure, Chronic
Enrolling
30 people
Starts
2026-09-08
Est. completion
2026-12-28
Design
Open-label, non-randomized, parallel groups, Phase 1
Record
View on ClinicalTrials.gov ↗